Early Exposure to Common Plasticizer Linked to Lifelong Anxiety

A recent study presented at the Endocrine Society’s annual meeting, ENDO 2026, suggests that early-life exposure to di-(2-ethylhexyl) phthalate (DEHP)—a ubiquitous plasticizer used in medical devices, toys, and household goods—may lead to persistent behavioral changes. Researchers from the University of Buenos Aires found that male rats exposed to DEHP during the prenatal and postnatal periods exhibited significantly higher levels of anxiety upon reaching adulthood. These animals displayed a marked hesitation to explore open environments and increased instances of freezing behavior, both of which are standard indicators of anxiety in rodent models.

To understand the underlying mechanisms, the research team investigated the roles of testosterone and gamma-aminobutyric acid (GABA), a primary inhibitory neurotransmitter. The study revealed that the anxiety induced by DEHP could be reversed by administering GABA agonists or testosterone. This suggests that the chemical may disrupt neurological development by interfering with these specific biological pathways, effectively 'rewiring' the brain during critical developmental windows.

While this study was conducted on rodents, the implications for human health are significant. Given the widespread presence of DEHP in modern consumer products, these findings highlight the potential risks of endocrine-disrupting chemicals during pregnancy and early childhood. If these behavioral effects translate to humans, it suggests that early environmental exposures could contribute to long-term mental health challenges. This research underscores the necessity for further investigation into how common industrial chemicals influence neurodevelopment and the potential for targeted interventions to mitigate these lasting impacts.